These independent CME/CE activities are supported by an educational grant from Takeda Oncology.



Clinical Context:
Multiple Myeloma
  1. Course List
Chair
Kenneth C. Anderson, MD
  • Kraft Professor of Medicine
  • Harvard Medical School
  • Director
  • Jerome Lipper Multiple Myeloma Center
  • Department of Medical Oncology
  • Dana-Farber Cancer Institute
  • Boston, Massachusetts

  • Faculty
    Sara Bringhen, MD, PhD
  • Assistant Professor
  • Myeloma Unit, Division of Hematology
  • Azienda Ospedaliera Città Della Salute E Della Scienza
  • Turin, Italy

  • Shaji K. Kumar, MD

    Jatin J. Shah, MD
  • Assistant Professor
  • Department of Lymphoma/Myeloma
  • MD Anderson Cancer Center
  • Houston, Texas
  • Disclosure Information
    Kenneth C. Anderson, MD   has received consulting fees from Celgene Corporation, Gilead Sciences, Millennium Pharmaceuticals, Onyx Pharmaceuticals, and Sanofi-Aventis; and has ownership interest in Acetylon Pharmaceuticals and OncoPep.

    Sara Bringhen, MD, PhD   has disclosed no significant relationships.

    Shaji K. Kumar, MD   has received consulting fees from Kesios Therapeutics and Noxxon Pharma AG; and has conducted contracted research for AbbVie Inc., Celgene Corporation, Janssen Pharmaceutical Companies of Johnson & Johnson,Merck & Co., Novartis Pharmaceuticals Corporation, Sanofi, and Takeda Pharmaceuticals.

    Jatin J. Shah, MD   has received consulting fees from and has conducted contracted research for Array BioPharma, Celgene Corporation, Millennium Pharmaceuticals, Novartis Pharmaceuticals Corporation, and Onyx Pharmaceuticals.